Marpai (MRAI) has released an update to notify the public and investors about an entry into a material definitive agreement.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Marpai, Inc. has renegotiated its purchase agreement with AXA S.A., adjusting the purchase price down by $3 million contingent on certain financial criteria being met by the company, including a significant shareholder equity contribution, maintaining stock exchange listings, and meeting payment deadlines. Additionally, Marpai signed a deal with Libertas Funding LLC to sell $2.193 million in future receipts for $1.7 million, with terms including an early delivery discount and an origination fee, backed by a personal guarantee from CEO Damien Lamendola.
For further insights into MRAI stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.